Table 1.

Clinical characteristics of 18 cases of ALSS-associated VVR.

Variable	Age (years)	Sex	BMI (kg/m2)	Etiology of liver injury	Glu (mmol/L)	ALT (U/L)	AST (U/L)	TBil (μmol/L)	INR
Patient 1	49	Male	23	Hepatitis B virus	9.7	57	135	583	2.15
Patient 2	62	Female	24	Hepatitis B virus	13.4	53	69	529	1.47
Patient 3	71	Male	21	Mixed	16.8	427	243	283	2.71
Patient 4	50	Female	19	Drugs	8.1	79	74	337	0.96
Patient 5	53	Male	21	Hepatitis B virus	7.8	183	74	202	0.92
Patient 6	59	Female	19	Cholestasis	10.2	425	383	366	1.19
Patient 7	73	Female	18	Drugs	14.9	213	249	175	0.92
Patient 8	54	Male	21	Hepatitis B virus	14.2	91	93	332	1.48
Patient 9	59	Female	21	Drugs	8.9	124	214	254	1.64
Patient 10	69	Female	22	Drugs	9.3	54	34	353	0.97
Patient 11	27	Male	19	Hepatitis B virus	8.7	97	89	372	1.41
Patient 12	62	Female	18	Cholestasis	12.4	151	69	333	1.12
Patient 13	44	Male	21	Hepatitis B virus	9.7	39	58	322	1.16
Patient 14	22	Male	23	Hepatitis B virus	6.7	77	94	401	1.3
Patient 15	74	Female	21	Hepatitis B virus	10.8	60	59	322	2.78
Patient 16	26	Male	28	Hepatitis B virus	9	113	165	548	1.49
Patient 17	67	Female	Unavailable	Mixed	11.6	92	133	398	2.68
Patient 18	37	Male	26	Hepatitis B virus	8.5	146	82	341	1.9

Note. ALSS: artificial liver support system; VVR: vasovagal reaction; BMI: body mass index; ALT: alanine aminotransferase; AST: aspartate aminotransferase; TBil: total bilirubin; INR: international normalized ratio; Glu: glucose.